Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Taxane-based combinations as adjuvant chemotherapy of early breast cancer: a meta-analysis of randomized trials 3. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer 4. 2008 Exclusive Survey—Earnings: Good news for primary care income 5. Paclitaxel plus bevacizumab versus paclitaxel alone for metastatic breast cancer
Top Ten Searches
post partum incontinence fibroid hpv colpotomy ovarian cyst curettage endometriosis intrauterine umbilical cordYour Article Summary
See Latest ArticlesPegylated liposomal doxorubicin combined with carboplatin: A rational treatment choice for advanced ovarian cancer
Critical Reviews in Oncology/Hematology, 09/30/09
Pignata S et al. – PLD–carboplatin is a promising chemotherapy combination. Phase III trials will elucidate whether it represents a new standard of care in ovarian cancer.
Related Articles
Correlation of Human Leukocyte Antigen-G (HLA-G) Expression and Disease Progression in Epithelial Ovarian Cancer
Reproductive Sciences, 10/09/09
Relevance Score: 89%
Ovarian cancer screening and early detection
Women's Health, 11/04/09
Relevance Score: 88%
Cytoreductive surgery and modified heated intraoperative intraperitoneal chemotherapy for advanced and recurrent ovarian cancer ? 12-year single center experience
European Journal of Surgical Oncology, 10/21/09
Relevance Score: 88%
Current status of anti-angiogenic agents in the treatment of ovarian carcinoma
Clinical and Translational Oncology, 10/07/09
Relevance Score: 88%
Histological response is not a prognostic factor after neoadjuvant chemotherapy in advanced-stage ovarian cancer with no residual disease
European Journal of Obstetrics & Gynecology and Reproductive Biology, 10/23/09
Relevance Score: 87%
Today in Clinical Pharmacology...keeping you current
Receive free subspecialty "5-minute updates" via email
Suppression of follicular rupture with meloxicam, a cyclooxygenase-2 inhibitor: potential for emergency contraception
Human Reproduction, 11/24/09
The rationale for mTOR inhibition in epithelial ovarian cancer
Expert Opinion on Investigational Drugs, 11/24/09
Factors contributing to gender differences in serum retinol and -tocopherol in infertile couples
Reproductive BioMedicine Online, 11/24/09
Today in Gynecologic Oncology...keeping you current
Receive free subspecialty "5-minute updates" via email
Paracentesis in Ovarian Cancer: A Study of the Physiology during Free Drainage of Ascites
Journal of Palliative Medicine, 11/25/09
How to deal with prognostic factors and radiotherapy results in uterine neoplasms with a sarcomatous component
Clinical and Translational Oncology, 11/25/09
Chemotherapy intensity and toxicity among black and white women with advanced and recurrent endometrial cancer
Cancer, 11/25/09
Sponsor
Article Search
Sponsor